Contract facts
FederalMELLANOX QUANTUM QM9700 INFINIBAND SWITCH is a federal award for National Institute Of Health Niehs held by Countertrade Products, Inc. Estimated value $217K ($217K obligated). Current period of performance ends Nov 5, 2024. Last award drew 4 bidders. Place of performance: DURHAM NC.
MELLANOX QUANTUM QM9700 INFINIBAND SWITCH
Recompete timing
PublicCurrent PoP ended Nov 5, 2024 (654 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.
Incumbent footprint
Public recordCountertrade Products, Inc — $1.1B obligated across 2,440 awards (firm-wide, all agencies) · lead buyer Department of Defense (DOD).
Related awards
Same parent · incumbentQuery this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Frequently asked questions
What is contract 75N96024F00006?
75N96024F00006 (Mellanox quantum qm9700 infiniband SWITCH) is a National Institute Of Health Niehs award with a potential value of $217K, currently held by Countertrade Products, Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.
Which office awarded 75N96024F00006?
National Institute Of Health Niehs awarded 75N96024F00006 to Countertrade Products, Inc (potential $217K).
Who is the incumbent on 75N96024F00006?
Countertrade Products, Inc is the incumbent with $1.1B across 2440 related awards in SCOUT’s public footprint. The current period of performance ends Nov 5, 2024.
When does Countertrade Products, Inc’s 75N96024F00006 come up for recompete?
SCOUT tracks a period-of-performance end of Nov 5, 2024. Actual solicitation timing can shift with extensions, bridges, or consolidations.
Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.
